Multiple Sclerosis
Conference Coverage
Can Exercise Boost Cognitive Performance in Patients With MS?
NEW ORLEANS—A single bout of treadmill walking might affect cognitive processing to a greater degree than stationary cycling, particularly among...
Conference Coverage
Researchers Compare Three Escalation Therapies for MS
BOSTON—Fingolimod and natalizumab are associated with similar rates of discontinuation, but the reasons for discontinuation differ significantly,...
Conference Coverage
When Should Neurologists Discontinue Disease-Modifying Treatments in Patients With MS?
NEW ORLEANS—Discontinuation of disease modifying treatments (DMTs) may be considered for patients with secondary progressive multiple sclerosis (...
Conference Coverage
Pregnancy and MS: How do they affect each other?
NEW ORLEANS – Researchers understand how MS affects pregnancy, but less about how pregnancy factors impact MS disease activity.
Conference Coverage
Study sheds light on pregnancy outcomes following ocrelizumab treatment
The study shows pregnancy outcomes data for women with multiple sclerosis, rheumatoid arthritis, and systemic lupus erythematosus.
Conference Coverage
What’s the evidence for stopping DMTs in MS patients?
NEW ORLEANS – In some situations it might be reasonable to discuss cessation of DMTs with patients.
Conference Coverage
DMD use during pregnancy low, study finds
NEW ORLEANS – The proportion of women with MS and a live birth receiving DMD treatment was low, but a relapse before pregnancy was more likely to...
Conference Coverage
Revisions coming to McDonald Criteria for MS
NEW ORLEANS – Increased emphasis on cerebrospinal fluid evaluation for some cases is one of the changes being considered.
Conference Coverage
Disease-Modifying Drug Treatment Before, During, and After Pregnancy in Women With MS
NEW ORLEANS—In a population of women with multiple sclerosis (MS) and a live birth, the rate of disease-modifying drug treatment...
Conference Coverage
Study offers snapshot of common MS comorbidities
NEW ORLEANS – Which comes first: Multiple sclerosis or the comorbidities?
Conference Coverage
Effective monitoring of DMTs for multiple sclerosis can be tricky
NEW ORLEANS – Documenting lab results in electronic medical records from patients coming from outside clinics proved to be difficult.